Metoprolol Tartrate
NDC Package 82727-002-03

11-digit billing NDC: 82727000203

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Metoprolol Tartrate is hypertensionMetoprolol tartrate tablets, USP are indicated for the treatment of hypertension. Marketed by Renata Limited (general Plant-2), this product is identified by NDC 82727-002 and is authorized under FDA application ANDA074453.

Identification & Billing

NDC Package Code
82727-002-03
Package Description
1000 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
82727000203
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Metoprolol Tartrate Film Coated
Dosage Form
-
Usage Information
HypertensionMetoprolol tartrate tablets, USP are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents.Angina PectorisMetoprolol tartrate tablets, USP is indicated in the long-term treatment of angina pectoris.Myocardial InfarctionMetoprolol tartrate tablets, USP are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous Metoprolol. Oral Metoprolol tartrate tablets, USP therapy can be initiated after intravenous Metoprolol therapy or, alternatively, oral treatment can begin within 3 to 10 days of the acute event (see DOSAGE AND ADMINISTRATION, CONTRAINDICATIONS, and WARNINGS).

Regulatory & Marketing

Labeler Name
Renata Limited (general Plant-2)
FDA Application #
ANDA074453
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-28-2023
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (82727-002). Click a package code to view its specific billing and regulatory data.

100 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82727-002-03 identifies a specific commercial package of 1000 tablet in 1 bottle of Metoprolol Tartrate Film Coated, labeled by Renata Limited (general Plant-2). This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Renata Limited (general Plant-2) on April 28, 2023. The current certification is valid through December 31, 2023.

How is this Renata Limited (general Plant-2) product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82727000203. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82727-002-03
11-Digit CMS (5-4-2)
82727-0002-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.